Guardant Health Expects FDA Approval Of Liquid Biopsy Test Will Strengthen Coverage, Adoption

 
• By Marion Webb

CEO sees Guardant360 CDx approval as "watershed moment" for liquid biopsy and plans more biopharma partnerships.

Array of blood samples for microscopy and biopsy tissue on blue gradient background

More from In Vitro Diagnostics

More from Diagnostics